Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO   US7142901039

PERRIGO COMPANY (PRGO)

4
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2014 4 011 M
EBIT 2014 944 M
Net income 2014 422 M
Debt 2014 2 404 M
Yield 2014 0,23%
Sales 2015 5 506 M
EBIT 2015 1 436 M
Net income 2015 661 M
Debt 2015 3 954 M
Yield 2015 0,22%
PER 2014 64,06
PER 2015 41,81
EV / Sales 2014 7,30x
EV / Sales 2015 5,60x
Capitalization 26 866 M
More Financials
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company operates its business through following segments: Consumer Healthcare, Nutritionals,... 
Sector
Pharmaceuticals
Calendar
08/13Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
12:56p TEVA PLANS TO RAISE MYLAN BID BY AS : Bloomberg
12:52pDJTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -Bloomberg
07/05 PERRIGO : BRIEF: Vigodman: If Mylan shareholders vote to buy Perrigo we'll withd..
06/29 Second-quarter M&A close to record amid mega deals
06/29 PERRIGO : Mylan seeks EC approval for takeover
06/26 PERRIGO : Change in Directors or Principal Officers, Financial Statements and Ex..
06/23 S&P 500 MOVERS : Wynn, prgo
06/22 PERRIGO : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Pharmaceuticals - NEC
05:42p ASTRAZENECA : Cephalon to pay to resolve Medicaid allegations - U.S
12:56p TEVA PLANS TO RAISE MYLAN BID BY AS : Bloomberg
12:52pDJTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -Bloomberg
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions